Wegovy Injection Pen – 0.5 mg x 4 Doses (Semaglutide)

Wegovy Injection Pen contains semaglutide, a medication that mimics the action of the natural hormone GLP-1 (glucagon-like peptide-1), which plays an important role in regulating appetite and glucose metabolism.

By activating GLP-1 receptors in the brain, semaglutide helps reduce hunger signals and increase feelings of fullness after meals. The medication also slows gastric emptying, meaning food remains in the stomach longer, which can help reduce overall calorie intake.

The 0.5 mg dose is typically introduced after the initial 0.25 mg phase, forming part of the step-by-step dose escalation used in Wegovy treatment programs. Each pen is pre-filled and designed for once-weekly subcutaneous injection, offering a convenient approach to weight management therapy.

Supports appetite control
Semaglutide helps regulate hunger signals in the brain, which may reduce cravings and overeating.

Encourages sustainable weight management
By promoting feelings of fullness, the medication may help support gradual and consistent weight reduction.

Step-up treatment progression
The 0.5 mg dose represents the second phase of treatment following the initial starting dose.

Once-weekly dosing
The injection pen provides a convenient weekly treatment routine.

Supports metabolic health
Improved appetite regulation and glucose metabolism may contribute to better long-term metabolic balance.

Wegovy (Semaglutide) Injection Pen – 0.5 mg is administered as a subcutaneous injection once per week.

General usage guidelines:

• Inject once weekly on the same day each week.

• The injection may be taken with or without meals.

• Recommended injection sites include the abdomen, thigh, or upper arm.

• Rotate injection sites between doses to reduce the risk of irritation.

• Follow the dosing schedule recommended by a healthcare professional.

The 0.5 mg dose is generally used after completing the initial 0.25 mg starting phase, allowing treatment to progress gradually toward higher maintenance doses if needed.

For best results, treatment should be combined with healthy nutrition, portion control, and regular physical activity.

Wegovy (Semaglutide) should be used only under the supervision of a qualified healthcare professional.

Important precautions include:

• Common side effects may include nausea, vomiting, diarrhea, constipation, or decreased appetite.

• Inform your healthcare provider about any medical conditions or medications before starting treatment.

• Individuals with a personal or family history of certain thyroid conditions should consult a healthcare professional before using semaglutide.

• Do not use the medication if you are allergic to semaglutide or any components of the formulation.

• Store the injection pen according to manufacturer guidelines, typically refrigerated until use.

If severe side effects or allergic reactions occur, discontinue use and seek medical attention immediately.